University of Limerick Institutional Repository

Development of in vitro models for the investigation of stent-cell interactions

DSpace Repository

Show simple item record

dc.contributor.advisor Soulimane, Tewfik
dc.contributor.advisor Hudson, Sarah P.
dc.contributor.author Ceresnakova, Miriama
dc.date.accessioned 2021-07-13T13:11:31Z
dc.date.available 2021-07-13T13:11:31Z
dc.date.issued 2021
dc.identifier.uri http://hdl.handle.net/10344/10342
dc.description peer-reviewed en_US
dc.description.abstract Although stenting as a medical procedure is well established, it is clear from clinical data that there is much left to learn about the long-term impact of in-stent restenosis (ISR) and how it can be prevented. Inadequacies in traditional 2D cell culture and poor in vitro and in vivo correlation contribute to this knowledge gap. In vitro cell studies of hydrophobic drugs, frequently used in drug eluting stents to combat ISR, face difficulties associated with their low aqueous solubility. Solubilization strategies that dissolve the drugs during in vitro assays result in drug concentrations that are not representative of those that will occur in vivo. This may result in non-representative changes in cell behavior, leading to further poor in vitro and in vivo correlation. Furthermore, a large share of the in vitro studies do not consider the dynamic flow of blood through a layer of cells, as occurs in the body. ISR, or re-narrowing of blood vessels, develops through a complex cascade of cellular events and is a pathological response to stent-induced vascular injury. Stent-induced vascular injury is manifested by removal of the endothelium and phenotypic changes in the underlying medial smooth muscle cells layer. This results in pathological vascular remodelling called neointimal hyperplasia (NIH). While drug-eluting stents contain anti-proliferative agents to inhibit the proliferation of smooth muscle cells (SMC), they also delay the regrowth of the intimal endothelial cells (EC) resulting in the subsequent development of late stent thrombosis. It is proposed that promoting rapid endothelial repair can minimize formation of NIH by preventing phenotypic switch in SMCs. The work presented in this thesis focuses on: i) a novel method development to investigate existing stent coatings and their impact on vascular repair, ii) evaluation of a novel bioactive stent coating candidate and its role in promoting vascular healing and iii) the establishment of a 3D cellularized tubular vascular model to bridge the gap between in vitro and in vivo studies. In the first phase of the project, a method for the preparation of stent conditioned media for in vitro evaluation of drug eluting stents was proposed and validated. In the next phase, citric acid as a novel bioactive candidate for stent coatings was investigated by studying its impact on endothelial growth and inflammation. As a last section of this project, a 3D vascular model was established and biomechanically characterized. en_US
dc.language.iso eng en_US
dc.publisher University of Limerick en_US
dc.subject in-stent restenosis (ISR) en_US
dc.subject medical procedure en_US
dc.title Development of in vitro models for the investigation of stent-cell interactions en_US
dc.type info:eu-repo/semantics/doctoralThesis en_US
dc.type.supercollection all_ul_research en_US
dc.type.supercollection ul_published_reviewed en_US
dc.type.supercollection ul_theses_dissertations en_US
dc.contributor.sponsor IRC en_US
dc.contributor.sponsor Cook Medical en_US
dc.rights.accessrights info:eu-repo/semantics/openAccess en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ULIR


Browse

My Account

Statistics